← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ocata Therapeutics, Inc.
Worcester, MA
$845,682
Total funding
4
Grants
Funding over time
peak $441.7K · FY2006–15$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$845,682 · 4
By mechanism
R43$641,243 · 3
R41$204,439 · 1
Investigators at Ocata Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Human embryonic stem cell-derived mesenchymal stromal cell therapy for lupus nephritis$225,639
R43 · FY2015 · AI
Retinitis pigmentosa therapy with human embryonic stem cell- and induced pluripotent stem cell-derived photoreceptor progenitors$216,072
R43 · FY2015 · EY
Directed Differentiation of Embryonic Stem Cells using Phage Displayed Ligands$204,439
R41 · FY2006 · DE
Defining Therapeutic Potential of Clonal Stem Cell Populations using Targeted Nan$199,532
R43 · FY2008 · GM